BCHE and early-onset autosomal dominant Alzheimer disease: The first approved cholinesterase inhibitor drug was Tacrine (tetrahydroaminoacridine) for the treatment of Alzheimer’s disease symptoms, which increases ACh in neurons, but during several trials, it was found to have hepatotoxic effects [2,33].